IP Verse

Crystalline Dapagliflozin Hydrate - EP2785702

The patent EP2785702 was granted to Sandoz on Jan 22, 2020. The application was originally filed on Nov 28, 2012 under application number EP12791764A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2785702

SANDOZ
Application Number
EP12791764A
Filing Date
Nov 28, 2012
Status
Opposition Rejected
Apr 27, 2024
Grant Date
Jan 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UK TRADING MYLANOct 22, 2020GILL JENNINGS & EVERYADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03099836
DESCRIPTIONWO2008002824
DESCRIPTIONWO2008116179
INTERNATIONAL-SEARCH-REPORTWO2008002824
OPPOSITIONWO2007028814
OPPOSITIONWO2008002824

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- CAIRA M R, "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, (19980101), vol. 198, doi:10.1007/3-540-69178-2_5, ISSN 0340-1022, pages 163 - 208, XP001156954
OPPOSITION- BAVIN M., "Polymorphism in Process Development", Chemistry & Industry, (19890821), pages 527 - 529, XP001180136
OPPOSITION- Federal Register, (19971224), vol. 62, no. 247, pages 67377 - 67388, XP055747833
OPPOSITION- Furniss et al., Vogel's Textbook of Practical Organic Chemistry, 5th ed., (19890000), pages 135 - 139, XP003004371
OPPOSITION- Gennaro, Remington: The Science and Practice of Pharmacy, (19950000), pages 168, 1452 - 1453, XP055475015
OPPOSITION- "Guidance for Industry - ANDAs: Pharmaceutical Solid Polymorphism - Chemistry, Manufacturing, and Controls Information", (20070700), XP055092048
OPPOSITION- L.M. HARWOOD et al., Experimental Organic Chemistry - Principles and Practice, (19890000), pages 127 - 139, XP055747816
OPPOSITION- MINO R. CAIRA, "Crystalline Polymorphism of Organic Compounds", Topics in Current Chemistry, (19980000), vol. 198, doi:10.1007/3-540-69178-2_5, XP008166276
OPPOSITION- Raw et al., "Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)", Advanced Drug Delivery Reviews, (20040000), vol. 56, pages 397 - 414, XP002422195
OPPOSITION- BYRN S. et al., "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950700), vol. 12, no. 7, pages 945 - 954, XP000996386

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents